Search Results - "Fino, Kristin K"

SH3GLB2/endophilin B2 regulates lung homeostasis and recovery from severe influenza A virus infection by Fino, Kristin K., Yang, Linlin, Silveyra, Patricia, Hu, Sanmei, Umstead, Todd M., DiAngelo, Susan, Halstead, E. Scott, Cooper, Timothy K., Abraham, Thomas, Takahashi, Yoshinori, Zhou, Zhixiang, Wang, Hong Gang, Chroneos, Zissis C.

“…New influenza A viruses that emerge frequently elicit composite inflammatory responses to both infection and structural damage of alveolar-capillary barrier…”
Get full text

A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer by Smith, Jill P., Harms, John, Matters, Gail L., McGovern, Christopher O., Ruggiero, Francesca M., Liao, Jiangang, Fino, Kristin K., Ortega, Emily E., Gilius, Evan L., Phillips III, John A.

“…There currently are no tests available for early diagnosis or for the identification of patients at risk for development of pancreatic cancer. We report the…”
Get full text

Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis by Fino, Kristin K, Matters, Gail L, McGovern, Christopher O, Gilius, Evan L, Smith, Jill P

“…Gastrin stimulates the growth of pancreatic cancer cells through the activation of the cholecystokinin-B receptor (CCK-BR), which has been found to be…”
Get more information

M1746 Identification of the CCK-C Spliced Receptor in Human Pancreatic Cancer Cells by Smith, Jill P, Harms, John F, Matters, Gail L, McGovern, Christopher O, Fino, Kristin K, Jayakumar, Calpurnia

Get full text

Atezolizumab for Advanced Alveolar Soft Part Sarcoma by Chen, Alice P., Sharon, Elad, O’Sullivan-Coyne, Geraldine, Moore, Nancy, Foster, Jared C., Hu, James S., Van Tine, Brian A., Conley, Anthony P., Read, William L., Riedel, Richard F., Burgess, Melissa A., Glod, John, Davis, Elizabeth J., Merriam, Priscilla, Naqash, Abdul R., Fino, Kristin K., Miller, Brandon L., Wilsker, Deborah F., Begum, Asma, Ferry-Galow, Katherine V., Deshpande, Hari A., Schwartz, Gary K., Ladle, Brian H., Okuno, Scott H., Beck, Jill C., Chen, James L., Takebe, Naoko, Fogli, Laura K., Rosenberger, Christina L., Parchment, Ralph E., Doroshow, James H.

“…Alveolar soft part sarcoma is a rare mesenchymal tumor with characteristic gene rearrangement that creates an ASPL–TFE3 fusion protein. In a phase 2 study,…”
Get full text

A phase 2 study of an anti–PD-L1 antibody (atezolizumab) in dedifferentiated chondrosarcoma by Salkeni, Mohamad Adham, Ko, Brian, Van Tine, Brian Andrew, Conley, Anthony Paul, Davis, Elizabeth J., Burgess, Melissa Amber, Close, Julia Lee, Foster, Jared C., O'Sullivan Coyne, Geraldine Helen, Moore, Nancy, Fino, Kristin K., Ferry-Galow, Katherine V., Rosenberger, Christina, Parchment, Ralph E., Sharon, Elad, Doroshow, James H., Chen, Alice P.

“…11533 Background: Chondrosarcoma (CS) is one of the most common bone malignancies in adults. Contrary to the indolent nature of low-grade CS, the…”
Get full text

A phase 2 study of anti-PD-L1 antibody (atezolizumab) in grade 2 and 3 chondrosarcoma by Salkeni, Mohamad Adham, Conley, Anthony Paul, Chen, James Lin, Davis, Elizabeth J., Burgess, Melissa Amber, Abdul Razak, Albiruni Ryan, Moore, Nancy, Ferry-Galow, Katherine V., Fino, Kristin K., Fung, King Leung, Parchment, Ralph E., Foster, Jared C., Rosenberger, Christina, O'Sullivan Coyne, Geraldine Helen, Takebe, Naoko, Sharon, Elad, Doroshow, James H., Chen, Alice P.

“…11528 Background: Chondrosarcoma is one of the most common bone malignancies in adults, and the third most common in pediatric patients (pts). The most…”
Get full text

Phase II study of atezolizumab in advanced alveolar soft part sarcoma (ASPS) by Naqash, Abdul Rafeh, O'Sullivan Coyne, Geraldine Helen, Moore, Nancy, Sharon, Elad, Takebe, Naoko, Fino, Kristin K., Ferry-Galow, Katherine V., Hu, James S., Van Tine, Brian Andrew, Burgess, Melissa Amber, Read, William L., Riedel, Richard F., George, Suzanne, Glod, John, Conley, Anthony Paul, Foster, Jared C., Fogli, Laura K., Parchment, Ralph E., Doroshow, James H., Chen, Alice P.

“…Abstract only 11519 Background: ASPS constitutes < 1% of soft tissue sarcomas and frequently presents in adolescents and young adults. There are no approved…”
Get full text

SP-R210 (Myo18A) enhances influenza A virus pathogenicity by alveolar macrophages and dendritic cells in vivo by Fino, Kristin K, Yang, Linlin, Hu, Sanmei, Halstead, Scott E, DiAngelo, Susan L, Silveyra, Patricia, Chroneos, Zissis C

“…Abstract Alveolar macrophages (AMs) are critical for the host response to severe influenza A virus (IAV) infection; IAV is known to cause abortive infection in…”
Get full text

Abstract CT263: Atezolizumab clinical trial biopsies reveal varied immune landscapes in clear cell sarcoma and chondrosarcoma by Ferry-Galow, Katherine V., Fino, Kristin K., Coyne, Geraldine O'Sullivan, Moore, Nancy, Sharon, Elad, Burgess, Melissa, Chen, James, Conley, Anthony P., Davis, Elizabeth J., Merriam, Priscilla, Razak, Albiruni R. Abdul, Van Tine, Brian, Foster, Jared C., Takebe, Naoko, Rosenberger, Christina L., Doroshow, James H., Chen, Alice P., Parchment, Ralph E.

“…Abstract Introduction: Clear cell sarcoma (CCS) constitutes <1% of sarcomas and frequently presents in adolescents and young adults. Chondrosarcoma is one of…”
Get full text

Abstract CT115: Safety and efficacy of Anti-PD-L1 antibody MEDI4736 (durvalumab) in combination with capecitabine in patients with advanced solid tumors (DURVA+) by Salkeni, Mohamad Adham, O’Sullivan Coyne, Geraldine, Takebe, Naoko, Sharon, Elad, Streicher, Howard, Mukherjee, Jessica, Bruns, Ashley, Mitra, Arjun, Naqash, Abdul R., Rubinstein, Larry, Fino, Kristin K., Fung, King L., Ferry-Galow, Katherine, Parchment, Ralph, Chen, Helen, Doroshow, James, Chen, Alice

“…Abstract Background: It is hypothesized that chemotherapy alters the tumor microenvironment (TME) by increasing T cell infiltration and enhancing antigen…”
Get full text

Abstract 2891: Gastrin signaling and Par-4 in pancreatic cancer by Fino, Kristin K., Irby, Rosalyn B., Smith, Jill P.

“…Abstract Background: The gastrointestinal peptide, gastrin, has been identified as a growth factor in pancreatic cancer. Gastrin stimulates growth of…”
Get full text

Abstract 4132: Down Regulation of the CCK-B/C Receptor Inhibits Growth of Pancreatic Cancer by Fino, Kristin K., Matters, Gail L., McGovern, Christopher O., Kester, Mark, Smith, Jill P.

“…Abstract Background: Pancreatic cancer has a dismal prognosis with only 1% surviving 5 years. Reasons for this poor prognosis include the inability to…”
Get full text

Role of the cholecystokinin-B receptor in proliferation of pancreatic cancer by Fino, Kristin K

“…Pancreatic cancer ranks as the fourth most common cause of cancer-related mortality with a five-year survival rate of less than 1% and a median survival of 3-6…”
Get full text